BioAge Labs, Inc. (BIOA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 391.86M | 286.79M | 290.83M | 301.7M | 324.81M | 357.1M | 336.47M | 163.65M | 178.81M | 25.31M | 0 |
| Cash & Short-Term Investments | 383.19M | 281.1M | 285.78M | 297.3M | 320.52M | 354.35M | 334.47M | 159.09M | 173.99M | 21.64M | 0 |
| Cash Only | 241.78M | 188.89M | 215.57M | 220.33M | 257.49M | 354.35M | 334.47M | 159.09M | 173.99M | 21.64M | 0 |
| Short-Term Investments | 141.42M | 92.21M | 70.2M | 76.97M | 63.03M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 709K | 769K | 515K | 603K | 361K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 23.99 | 19.19 | 25.04 | 18.18 | 22.39 | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.96M | 4.93M | 4.54M | 3.8M | 3.93M | 2.75M | 1.99M | 4.57M | 4.81M | 3.66M | 0 |
| Total Non-Current Assets | 5.79M | 8.1M | 14.26M | 20.45M | 19.03M | 1.13M | 914K | 750K | 796K | 618K | 0 |
| Property, Plant & Equipment | 3.8M | 3.75M | 3.86M | 4.01M | 4.13M | 791K | 814K | 625K | 696K | 518K | 0 |
| Fixed Asset Turnover | 0.73x | 0.81x | 0.52x | 0.59x | 0.59x | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 100K | 100K | 100K | 16.21M | 14.66M | 100K | 100K | 100K | 100K | 100K | 0 |
| Other Non-Current Assets | 1.9M | 4.25M | 10.3M | 237K | 239K | 240K | 0 | 25K | 0 | 0 | 0 |
| Total Assets | 397.65M | 294.89M | 305.09M | 322.15M | 343.84M | 358.23M | 337.38M | 164.4M | 179.6M | 25.92M | 0 |
| Asset Turnover | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | - | - | - | - | - | - |
| Asset Growth % | 15.65% | -17.68% | -9.57% | 95.95% | 91.45% | 1281.86% | - | - | - | - | - |
| Total Current Liabilities | 15.83M | 20.14M | 24.49M | 22.84M | 23.74M | 27.77M | 19.08M | 12.98M | 15.14M | 58.17M | 0 |
| Accounts Payable | 3.07M | 2.67M | 5.02M | 1.33M | 3.99M | 2M | 2.1M | 1.47M | 2.32M | 1.87M | 0 |
| Days Payables Outstanding | 4.1K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.16M | 2.65M | 4.13M | 5.6M | 6M | 6M | 6M | 6M | 6M | 44.86M | 0 |
| Deferred Revenue (Current) | 6.19M | 5.75M | 7.51M | 7.7M | 8.18M | 7.83M | 0 | 0 | 0 | 3.31M | 0 |
| Other Current Liabilities | 714K | 525K | 890K | 911K | 558K | 417K | 1.74M | 1.3M | 3.89M | 1.39M | 0 |
| Current Ratio | 24.76x | 14.24x | 11.87x | 13.21x | 13.68x | 12.86x | 17.63x | 12.61x | 11.81x | 0.44x | - |
| Quick Ratio | 24.76x | 14.24x | 11.87x | 13.21x | 13.68x | 12.86x | 17.63x | 12.61x | 11.81x | 0.44x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.71M | 2.7M | 3.13M | 4.53M | 6.94M | 7.33M | 4.55M | 348.55M | 349.97M | 141.15M | 0 |
| Long-Term Debt | 2.23M | 2.33M | 0 | 0 | 1.06M | 2.5M | 3.94M | 5.37M | 6.79M | 8.2M | 0 |
| Capital Lease Obligations | 0 | 0 | 2.43M | 2.52M | 2.56M | 0 | 0 | 43K | 110K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 477K | 370K | 150K | 108K | 97K | 156K | 613K | 343.14M | 343.07M | 132.95M | 0 |
| Total Liabilities | 18.53M | 22.84M | 27.63M | 27.37M | 30.67M | 35.11M | 23.63M | 361.53M | 365.11M | 199.32M | 0 |
| Total Debt | 4.03M | 5.56M | 7.13M | 8.75M | 10.31M | 8.7M | 10.21M | 11.71M | 13.2M | 53.25M | 0 |
| Net Debt | -237.74M | -183.33M | -208.44M | -211.58M | -247.17M | -345.64M | -324.26M | -147.37M | -160.79M | 31.61M | 0 |
| Debt / Equity | 0.01x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -569.59x | -280.99x | -134.38x | -106.28x | -49.70x | -65.24x | -59.33x | -29.66x | -9.68x | -7.19x | -14.51x |
| Total Equity | 379.12M | 272.05M | 277.46M | 294.78M | 313.17M | 323.13M | 313.75M | -197.13M | -185.51M | -173.4M | 0 |
| Equity Growth % | 21.06% | -15.81% | -11.56% | 249.54% | 268.81% | 286.35% | - | - | - | - | - |
| Book Value per Share | 8.92 | 7.53 | 7.74 | 8.22 | 8.74 | 9.01 | 9.17 | -5.77 | -5.42 | -5.07 | - |
| Total Shareholders' Equity | 379.12M | 272.05M | 277.46M | 294.78M | 313.17M | 323.13M | 313.75M | -197.13M | -185.51M | -173.4M | 0 |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -355.67M | -333.42M | -307.47M | -287.3M | -265.74M | -252.81M | -231.68M | -208.28M | -194.69M | -181.7M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 73K | 278K | 275K | 212K | 264K | 245K | 109K | 167K | 185K | 164K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |